Respiratory – September 2020 Respiratory – September 2020 Breztri Aerosphere approved in the US for the maintenance treatment of COPD 24 Jul 2020 Breztri Aerosphere (Budesonide/glycopyrrolate/formoterol fumarate, ICS/LAMA/LABA) – AstraZeneca Now approved in the US for maintenance treatment of patients […]
Respiratory – September 2020 Respiratory – September 2020 FDA approved Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of Asthma in the US 09 Sep 2020 Trelegy Ellipta (Fluticasone furoate/umeclidinium/vilanterol, ICS/LAMA/LABA) – GlaxoSmithKline (GSK)/ Innoviva […]
Respiratory – September 2020 Respiratory – September 2020 Dupixent (dupilumab) long-term data show sustained improvement in lung function and reduction in severe exacerbations in adults and adolescents with moderate-to-severe Asthma 08 Sep 2020 Dupixent (Dupilumab, Anti-IL-4Rα mAb) – Sanofi/Regeneron New […]
Respiratory – September 2020 Respiratory – September 2020 Breztri Aerosphere approved in the US for the maintenance treatment of COPD Enerzair Breezhaler (QVM149; Mometasone furoate, glycopyrronium bromide and indacaterol acetate, ICS/LAMA/LABA) – Novartis 07 Jul 2020 European Commission (EC) approved […]
Respiratory – September 2020 Respiratory – September 2020 Verona Pharma published and presented Part A Phase 2b symptom data and initiated multiple dose part of Phase 2 trial of Ensifentrine in COPD Ensifentrine (RPL554, PDE 3 and 4 inhibitor) – […]
Respiratory – September 2020 Respiratory – September 2020 Knopp Biosciences completes patient enrollment for dexpramipexole’s Phase 2 trial in patients with moderate to severe eosinophilic Asthma 16 Sep 2020 Dexpramipexole (KNS-760704, Eosinophil depletion) – Knopp Biosciences Knopp Biosciences completed the […]
Respiratory – September 2020 Respiratory – September 2020 FDA Accepts Application for Xolair (omalizumab) prefilled syringe for self-administration across all indications 12 Aug 2020 Xolair (Omalizumab, Anti-IgE mAb) – Genentech/Novartis The application acceptance is based on the well-established efficacy and […]
Respiratory – September 2020 Respiratory – September 2020 Propeller health enters Japan via collaboration with Novartis to connect the Propeller digital health platform to Enerzair and Atectura Breezhaler 26 Aug 2020 Patients in Japan using Enerzair and Atectura Breezhaler to […]
